CYP2D6 genotyping and tamoxifen in the treatment of post-menopausal breast cancer - a reply

Br J Clin Pharmacol. 2014 Aug;78(2):433-4. doi: 10.1111/bcp.12330.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Cytochrome P-450 CYP2D6 / genetics*
  • Female
  • Humans
  • Postmenopause / metabolism*
  • Tamoxifen / therapeutic use*
  • Treatment Outcome*

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Cytochrome P-450 CYP2D6